Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
(6) Khavinson VKh
Thomas, A
As patients are switching back to the name-brand medications, its important that we reconcile their medications and counsel them to stop usage of the compounded version
PubMed laboratory research record [PMID: 15944817] PubMed record related to this compound for laboratory literature review
Metabolism 77:6572 Gaborit B, Ancel P, Abdullah AE, Maurice F, Abdesselam I, Calen A, Soghomonian A, Houssays M, Varlet I, Eisinger M, Lasbleiz A, Peiretti F, Bornet CE, Lefur Y, Pini L, Rapacchi S, Bernard M, Resseguier N, Darmon P, Kober F, Dutour A (2021) Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study
US$ 29.52
US$ 23.53
US$ 21.14
US$ 26.37
US$ 26.42
US$ 22.95
US$ 28.77
